Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma-1b in cystic fibrosis
NCT00043316Phase 2Completed
- Sponsor
- InterMune
- Start
- Feb 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of interferon gamma-1b in cystic fibrosis (CF) (3 arms), sponsored by InterMune. Primary endpoints: Forced Expiratory Volume in 1 second at 12 weeks and Sputum Bacterial Density at 12 weeks. Started Feb 2001; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00043316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043316.